Single Nucleotide Polymorphisms in PLCE1 for Cancer Risk of Different Types: A Meta-Analysis

Background: Recent studies have investigated the relationships between PLCE1 polymorphisms and cancer susceptibility. However, some findings lack consistency. Objectives: In the current study, we conducted a meta-analysis to more accurately evaluate the relationships between PLCE1 (rs2274223, rs3765524, rs753724, rs11187842, and rs7922612) single nucleotide polymorphisms (SNPs) and risk for different types of cancer. Methods: We performed a comprehensive search strategy in PubMed, Web of Science, Medline, EMbase, and Scopus for articles available until 19 March 2018. A total of 54 case-control studies comprising 17,955 cases and 20,400 controls were included in the current meta-analysis, which together comprised a total of 32 publications. The pooled odds ratios (ORs) with 95% confidence intervals (CIs) were used to evaluate relationships between the PLCE1 polymorphisms and cancer susceptibility. All statistical analyses were performed using Stata 11 software. Results: Results of the meta-analysis demonstrated that the rs2274223 polymorphism showed a significant correlation with increased overall cancer susceptibility (AG vs. AA: OR 1.168, 95% CI 1.084–1.259; GG vs. AA: OR 1.351, 95% CI 1.163–1.570; AG+GG vs. AA: OR 1.193, 95% CI 1.103–1.290; GG vs. AA+AG: OR 1.262, 95% CI 1.102–1.446; G vs. A: OR 1.163, 95% CI 1.089–1.242). Results of subgroup analysis showed that the rs2274223 polymorphism was associated with higher risk for esophageal cancer and gastric cancer relative to colorectal cancer and head and neck cancer. In addition, the rs2274223 polymorphism was found to be associated with increased cancer risk, especially among the subgroups comprising Asians, studies with population-based controls, studies employing the TaqMan genotyping method, and studies consistent with Hardy-Weinberg equilibrium (HWE). The association between the rs3765524 polymorphism and reduced overall cancer risk was detected in one specific genetic model (CT vs. CC: OR 0.681, 95% CI 0.523–0.886). Results of subgroup analysis showed that the rs3765524 polymorphism was associated with cancer risk in a specific genetic model among the subgroups of colorectal cancer, esophageal cancer, Asians, studies with population-based controls, and studies consistent with HWE. However, relationships among the PLCE1 rs753724, rs11187842, and rs7922612 polymorphisms and tumor risk were not identified. Conclusions: Results of the current meta-analysis suggested that PLCE1 (rs2274223, rs3765524) polymorphisms are associated with cancer susceptibility.

[1]  M. Burns,et al.  Case-Control Study , 2020, Definitions.

[2]  Wenbo Li,et al.  Association between PRKAA1 rs13361707 T>C polymorphism and gastric cancer risk , 2018, Medicine.

[3]  Özhan Gül,et al.  Genetic Variations in Phospholipase C-epsilon 1 (PLCE1) and Susceptibility to Colorectal Cancer Risk , 2016, Biochemical Genetics.

[4]  Lijing Yang,et al.  MicroRNA-1976 functions as a tumor suppressor and serves as a prognostic indicator in non-small cell lung cancer by directly targeting PLCE1. , 2016, Biochemical and biophysical research communications.

[5]  L. Shen,et al.  Risk prediction for early-onset gastric carcinoma: a case-control study of polygenic gastric cancer in Han Chinese with hereditary background , 2016, Oncotarget.

[6]  L. Dai,et al.  Two novel polymorphisms in PLCE1 are associated with the susceptibility to esophageal squamous cell carcinoma in Chinese population. , 2016, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[7]  Q. Lu,et al.  Simultaneous esophagectomy and off-pump coronary artery bypass grafting: a practicable approach with good survival. , 2016, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[8]  A. Jemal,et al.  Cancer statistics in China, 2015 , 2016, CA: a cancer journal for clinicians.

[9]  Yan Deng,et al.  Genetic Variation of BCL2 (rs2279115), NEIL2 (rs804270), LTA (rs909253), PSCA (rs2294008) and PLCE1 (rs3765524, rs10509670) Genes and Their Correlation to Gastric Cancer Risk Based on Universal Tagged Arrays and Fe3O4 Magnetic Nanoparticles. , 2015, Journal of biomedical nanotechnology.

[10]  P. Liu,et al.  Genetic variants at 6p21, 10q23, 16q21 and 22q12 are associated with esophageal cancer risk in a Chinese Han population. , 2015, International journal of clinical and experimental medicine.

[11]  T. Jin,et al.  The association between phospholipase C epsilon gene (PLCE1) polymorphisms and colorectal cancer risk in a Chinese Han population: a case-control study. , 2015, International journal of clinical and experimental medicine.

[12]  L. Jonaitis,et al.  Common Genetic Variants of PSCA, MUC1 and PLCE1 Genes are not Associated with Colorectal Cancer. , 2015, Asian Pacific journal of cancer prevention : APJCP.

[13]  J. Chen,et al.  Evaluating the Association of Eight Polymorphisms with Cancer Susceptibility in a Han Chinese Population , 2015, PloS one.

[14]  Nobhojit Roy,et al.  The Global Burden of Cancer 2013. , 2015, JAMA oncology.

[15]  K. Pooley,et al.  Genetic variation and gastric cancer risk: a field synopsis and meta-analysis , 2015, Gut.

[16]  Y. Li,et al.  Associations of Genetic Variants in the PSCA, MUC1 and PLCE1 Genes with Stomach Cancer Susceptibility in a Chinese Population , 2015, PloS one.

[17]  Meiling Zhu,et al.  Association between PLCE1 rs2274223 A > G polymorphism and cancer risk: proof from a meta-analysis , 2015, Scientific Reports.

[18]  P. Malfertheiner,et al.  PSCA and MUC1 gene polymorphisms are associated with gastric cancer and pre-malignant gastric conditions [corrected]. , 2014, Anticancer research.

[19]  M. Zhai,et al.  PLCE1 rs2274223 polymorphism and susceptibility to esophageal cancer: a meta-analysis. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[20]  B. Mittal,et al.  Phospholipase C epsilon 1 (PLCE1) Haplotypes are Associated with Increased Risk of Gastric Cancer in Kashmir Valley , 2014, Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association.

[21]  L. Cui,et al.  Replication of results of genome-wide association studies on esophageal squamous cell carcinoma susceptibility loci in a Korean population. , 2014, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[22]  U. Ghoshal,et al.  Role of novel and GWAS originated PLCE1 genetic variants in susceptibility and prognosis of esophageal cancer patients in northern Indian population , 2014, Tumor Biology.

[23]  Z. Liao,et al.  HPV seropositivity joints with susceptibility loci identified in GWASs at apoptosis associated genes to increase the risk of Esophageal Squamous Cell Carcinoma (ESCC) , 2014, BMC Cancer.

[24]  B. Mittal,et al.  A multigenic approach to evaluate genetic variants of PLCE1, LXRs, MMPs, TIMP, and CYP genes in gallbladder cancer predisposition , 2014, Tumor Biology.

[25]  Jinhan Wang,et al.  PLCE1 rs2274223 polymorphism contributes to risk of esophageal cancer: evidence based on a meta-analysis , 2014, Tumor Biology.

[26]  Fanlong Liu,et al.  Association between phospholipase C epsilon gene (PLCE1) polymorphism and colorectal cancer risk in a Chinese population , 2014, The Journal of international medical research.

[27]  Xue-ping Luo.  Phospholipase C ε‐1 inhibits p53 expression in lung cancer , 2014, Cell biochemistry and function.

[28]  M. Shin,et al.  Common genetic variants at 1q22 and 10q23 and gastric cancer susceptibility in a Korean population , 2014, Tumor Biology.

[29]  Xiao-bin Cui,et al.  [Relationship between rs2274223 and rs3765524 polymorphisms of PLCE1 and risk of esophageal squamous cell carcinoma in a Kazakh Chinese population]. , 2013, Zhonghua bing li xue za zhi = Chinese journal of pathology.

[30]  Xiao-bin Cui,et al.  Multiple polymorphisms within the PLCE1 are associated with esophageal cancer via promoting the gene expression in a Chinese Kazakh population. , 2013, Gene.

[31]  L. Dai,et al.  Novel functional variants locus in PLCE1 and susceptibility to esophageal squamous cell carcinoma: based on published genome-wide association studies in a central Chinese population. , 2013, Cancer epidemiology.

[32]  Junbo Hu,et al.  Helicobacter pylori Infection Synergizes with Three Inflammation-Related Genetic Variants in the GWASs to Increase Risk of Gastric Cancer in a Chinese Population , 2013, PloS one.

[33]  T. Wobbes,et al.  GWAS-uncovered SNPs in PLCE1 and RFT2 genes are not implicated in Dutch esophageal adenocarcinoma and squamous cell carcinoma etiology , 2013, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[34]  B. Mittal,et al.  Association of Potentially Functional Genetic Variants of PLCE1 with Gallbladder Cancer Susceptibility in North Indian Population , 2013, Journal of Gastrointestinal Cancer.

[35]  B. Mittal,et al.  PLCE1 rs2274223 A>G polymorphism and cancer risk: a meta-analysis , 2013, Tumor Biology.

[36]  Hongbing Shen,et al.  Genetic variants at 10q23 are associated with risk of head and neck cancer in a Chinese population. , 2013, Oral oncology.

[37]  Li Juan Yuan,et al.  Polymorphisms of tumor-related genes IL-10, PSCA, MTRR and NOC3L are associated with the risk of gastric cancer in the Chinese Han population. , 2012, Cancer epidemiology.

[38]  A. J. Palmer,et al.  Genetic variation in C20orf54, PLCE1 and MUC1 and the risk of upper gastrointestinal cancers in Caucasian populations , 2012, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[39]  C. Lewis,et al.  Distinct genetic association at the PLCE1 locus with oesophageal squamous cell carcinoma in the South African population. , 2012, Carcinogenesis.

[40]  R. Zhou,et al.  PLC-ε1 gene polymorphisms significantly enhance the risk of esophageal squamous cell carcinoma in individuals with a family history of upper gastrointestinal cancers. , 2012, Archives of medical research.

[41]  Menghong Sun,et al.  Putatively Functional PLCE1 Variants and Susceptibility to Esophageal Squamous Cell Carcinoma (ESCC): A Case–Control Study in Eastern Chinese Populations , 2012, Annals of Surgical Oncology.

[42]  H. Gu,et al.  Replication study of PLCE1 and C20orf54 polymorphism and risk of esophageal cancer in a Chinese population , 2012, Molecular Biology Reports.

[43]  Yingsong Wu,et al.  Association of 10q23 with colorectal cancer in a Chinese population , 2012, Molecular Biology Reports.

[44]  Hua-mei Tang,et al.  Phospholipase C epsilon plays a suppressive role in incidence of colorectal cancer , 2012, Medical Oncology.

[45]  Menghong Sun,et al.  Potentially Functional Variants of PLCE1 Identified by GWASs Contribute to Gastric Adenocarcinoma Susceptibility in an Eastern Chinese Population , 2012, PloS one.

[46]  Zhensheng Liu,et al.  Association between novel PLCE1 variants identified in published esophageal cancer genome-wide association studies and risk of squamous cell carcinoma of the head and neck , 2011, BMC Cancer.

[47]  Hongbing Shen,et al.  Genetic variants at 1q22 and 10q23 reproducibly associated with gastric cancer susceptibility in a Chinese population. , 2011, Carcinogenesis.

[48]  N. Schmitz,et al.  Risk stratification using a new prognostic score for patients with secondary acute myeloid leukemia: results of the prospective AML96 trial , 2011, Leukemia.

[49]  Bin Liu,et al.  Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies a susceptibility locus at PLCE1 , 2010, Nature Genetics.

[50]  N. Hu,et al.  A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma , 2010, Nature Genetics.

[51]  A. Stang.  Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses , 2010, European Journal of Epidemiology.

[52]  M. Dimatteo,et al.  Physician Communication and Patient Adherence to Treatment: A Meta-Analysis , 2009, Medical care.

[53]  E. Zintzaras,et al.  A field synopsis and meta-analysis of genetic association studies in peripheral arterial disease: The CUMAGAS-PAD database. , 2009, American journal of epidemiology.

[54]  J. Ioannidis,et al.  STrengthening the REporting of Genetic Association Studies (STREGA)— An Extension of the STROBE Statement , 2009, Annals of Internal Medicine.

[55]  Hua-mei Tang,et al.  Screening of new tumor suppressor genes in sporadic colorectal cancer patients. , 2008, Hepato-gastroenterology.

[56]  Xiaomei Ma,et al.  Global Burden of Cancer , 2006, The Yale journal of biology and medicine.

[57]  L. Bourguignon,et al.  Hyaluronan-CD44 Interaction with Leukemia-associated RhoGEF and Epidermal Growth Factor Receptor Promotes Rho/Ras Co-activation, Phospholipase Cϵ-Ca2+ Signaling, and Cytoskeleton Modification in Head and Neck Squamous Cell Carcinoma Cells* , 2006, Journal of Biological Chemistry.

[58]  Fernando Rodrigues-Lima,et al.  Structural and mechanistic insights into ras association domains of phospholipase C epsilon. , 2006, Molecular cell.

[59]  K. Dixon,et al.  Genetic alterations and DNA repair in human carcinogenesis. , 2004, Seminars in cancer biology.

[60]  T Kendall Harden,et al.  PLC-epsilon: a shared effector protein in Ras-, Rho-, and G alpha beta gamma-mediated signaling. , 2003, Molecular interventions.

[61]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[62]  C. Begg,et al.  Operating characteristics of a rank correlation test for publication bias. , 1994, Biometrics.

[63]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[64]  W. Haenszel,et al.  Statistical aspects of the analysis of data from retrospective studies of disease. , 1959, Journal of the National Cancer Institute.

[65]  A. Jemal,et al.  Cancer statistics, 2018 , 2018, CA: a cancer journal for clinicians.

[66]  M. Zhai,et al.  PLCE 1 rs 2274223 Polymorphism and Susceptibility to Esophageal Cancer : a Meta-analysis , 2014 .

[67]  Hongbing Jiang,et al.  Meta-analysis of phospholipase C epsilon 1 polymorphism and cancer risk. , 2013, Cancer biomarkers : section A of Disease markers.

[68]  Matilda Katan,et al.  Regulatory links between PLC enzymes and Ras superfamily GTPases: signalling via PLCepsilon. , 2009, Advances in enzyme regulation.